Navigation Links
Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
Date:5/16/2010

designed to extend life and improve the quality of life for patients with cancer and diabetes/obesity. For additional information about OSI, please visit http://www.osip.com.

Important additional information

This press release is for informational purposes only and does not constitute an offer to purchase or a solicitation of an offer to sell OSI's common stock. The tender offer ("Tender Offer") is being made pursuant to a tender offer statement on Schedule TO (including the offer to purchase, letter of transmittal and other related tender offer materials) initially filed by Astellas Pharma Inc. ("Astellas") with the Securities and Exchange Commission (the "SEC") on March 2, 2010. These materials, as they may be amended from time to time, contain important information, including the terms and conditions of the offer, that should be read carefully before any decision is made with respect to the Tender Offer. Investors and shareholders can obtain a free copy of these materials and other documents filed by Astellas with the SEC at the website maintained by the SEC at www.sec.gov. The Tender Offer materials may also be obtained for free by contacting the information agent for the tender offer, Georgeson Inc. at (212) 440-9800.

OSI Pharmaceuticals' ("OSI") stockholders should read the company's solicitation/recommendation statement on schedule 14D-9, which was initially filed with the SEC on March 15, 20
'/>"/>

SOURCE Astellas Pharma US, Inc.; OSI Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC
2. Astellas Pharma US, Inc. and The International Transplant Nurses Society (ITNS) Collaborate on Content for Transplant Experience Program
3. Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
4. CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection
5. Astellas Launches Lexiscan(TM) (Regadenoson) Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging (MPI)
6. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
7. CV Therapeutics Statement on Unsolicited Proposal From Astellas
8. CV Therapeutics Board of Directors Rejects Astellas Unsolicited Proposal
9. CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas Tender Offer
10. CV Therapeutics Board of Directors Rejects Astellas Tender Offer
11. Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... (PRWEB) July 10, 2014 Terascala, the ... announced that Alan Swahn, a former vice president of ... team as vice president of marketing. Terascala’s software when ... and NetApp create the highest performance and most reliable ... appointed to guide Terascala’s channel expansion and broaden its ...
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, Inc., ... the relaunch of his highly informative blog, now named Stem ... What are Stem Cells ?” Dr. Harman’s purpose for ... the basics of stem cell therapy so that pet owners ... treatment when considering regenerative medicine. , A veterinarian by trade, ...
(Date:7/10/2014)... EvoDerma ’s NOOME Anti-Aging Motion has ... now comes with a second treatment cup to help prevent ... new cup is thinner on the edges for a softer ... thin and uneven surfaces on the face, neck and décolleté. ... treatment on areas such as the cheeks and neck, or ...
(Date:7/10/2014)... 10, 2014  Franciscan St. Anthony Health-Crown ... for respiratory monitoring outside the operating room, ... in embracing state-of-the-art patient safety technology. ... breathing and can alert medical caregivers when ... amount of carbon dioxide the patient is ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2
... Research has shown that certain marginalized groups including ... as African Americans and Latinos fare worse than ... impoverishment, injuries and fatalities. , Now, ... found that they also experience greater terrorism-related fears and ...
... an early warning system for potential ecological disasters, ... Stockholm University and the University of East Anglia. ... food production are of fundamental importance for all ... changes in ecosystems caused by various pressures like ...
... Receives Positive Committee Recommendation in European UnionSAN MATEO, Calif., ... ), a biopharmaceutical company focused on developing and commercializing ... a conference call on Friday, March 20, 2009 at ... quarter and year-end 2008 results and the European Medicines ...
Cached Biology Technology:Disabled and other vulnerable groups more susceptible to terrorism fears 2Internet can warn of ecological changes 2Internet can warn of ecological changes 3NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update 2NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update 3NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update 4
(Date:7/10/2014)... scientists have discovered that scorpions create a platform in ... hunt. , As ectothermic animals, scorpions rely on ... researchers believe that this platform provides a safe, warm ... before they leave their hiding places to forage at ... ( Scorpio maurus palmatus ) in Israel,s Negev desert ...
(Date:7/10/2014)... Amyloid diseases, such as Alzheimer,s disease, type ... share the common trait that proteins aggregate into ... vitro studies have found that neither the amylin ... toxic. New evidence using two-dimensional infrared (2D IR) ... amylin aggregation pathway that may explain toxicity, opening ...
(Date:7/10/2014)... Satellite or GOES-West satellite spotted smoke over the ... Canada,s Northwestern Territories. , At 1200 UTC (8 ... this image of the brownish-colored haze created by ... all the way into South Dakota. This image ... NASA Goddard Space Flight Center, Greenbelt, Md. ...
Breaking Biology News(10 mins):Scorpions are master architects, according to new research from Ben-Gurion University 2New technology reveals insights into mechanisms underlying amyloid diseases 2
... standard laboratory conditions, the human beta-defensin 1 (hBD-1), a ... shown only little activity against microbes. Nevertheless the human ... the puzzle was the investigation process itself, as the ... Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology of the ...
... 21, 2011 Cancer Research Institute, Inc. (CRI), a ... science of tumor immunology and foster the discovery and ... Cancer Vaccine Acceleration Fund (CVAF), a joint initiative with ... completed a new investment agreement with Oncovir, Inc., a ...
... network in Mauritania, on the north west coast of ... as well as being home to two of the ... monk seal and the Atlantic hump-backed dolphin. The results ... activities along the coast are putting these mammals and ...
Cached Biology News:Defense mechanism against bacteria and fungi deciphered 2Cancer Research Institute invests $450k in Oncovir to manufacture powerful immune stimulant 2Cancer Research Institute invests $450k in Oncovir to manufacture powerful immune stimulant 3Monk seal and hump-backed dolphin are threatened by fishing activities off coast of Mauritania 2